AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
In older adults with type 2 diabetes, muscle size may mediate the association between body mass index and mortality, according to research published online Oct. 14 in Diabetes Care.
When walking up and down stairs, patients with diabetic peripheral neuropathy are slower at generating strength at the ankle and knee compared to control participants, which may increase the risk of falls, according to a study published online Oct. 14 in Diabetes Care.
Living a healthy lifestyle may decrease the risk of heart failure among women, even in the absence of antecedent coronary heart disease, hypertension, and diabetes, according to research published in the Oct. 28 issue of the Journal of the American College of Cardiology.
Telephone outreach does not improve medication adherence or metabolic control in adults with diabetes, according to a study published online Oct. 14 in Diabetes Care.
Cardiovascular disease (CVD) is a long-term complication of type 1 diabetes mellitus (T1DM), and more attention toward management of its associated risk factors and modifiers is urged in a scientific statement published in the October issue of Diabetes Care.